Auris Medical Holding Ltd. (EARS) Social Stream



Auris Medical Holding Ltd. (EARS): $3.05

-0.05 (-1.61%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EARS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 495

in industry

Auris Medical Holding Ltd (EARS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering EARS.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
1 $15.55159 $15.55159 $15.55159 $3.1 401.66%

Price Target Last Issued October 21, 2019

The Trend in the Analyst Price Target


EARS's average price target has moved down $0.36 over the prior 0 secs.

Over the past 0 secs, EARS's average upside potential has been NA%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2019-10-21 1 15.91187 15.91187 15.91187 NA NA%
2019-10-21 1 15.17692 15.17692 15.17692 NA NA%
2019-10-21 1 15.46782 15.46782 15.46782 NA NA%
2019-10-21 1 15.91524 15.91524 15.91524 NA NA%
2019-10-21 1 15.88183 15.88183 15.88183 NA NA%
2019-10-21 1 15.65374 15.65374 15.65374 NA NA%
2019-10-21 1 14.30000 14.30000 14.30000 NA NA%
2019-10-21 1 15.54703 15.54703 15.54703 NA NA%
2019-10-21 1 15.92853 15.92853 15.92853 NA NA%
2019-10-21 1 15.86544 15.86544 15.86544 NA NA%
2019-10-21 1 15.59926 15.59926 15.59926 NA NA%
2019-10-21 1 15.52947 15.52947 15.52947 NA NA%
2019-10-21 1 15.64979 15.64979 15.64979 NA NA%
2019-10-21 1 15.55159 15.55159 15.55159 NA NA%

EARS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EARS as an investment opportunity.

  • EARS has a higher number of analysts covering the stock than practically none of all US stocks.
  • The variance in analysts' estimates of EARS is lower than just about 100% of all US stocks.
  • Auris Medical Holding Ltd's upside potential (average analyst target price relative to current price) is greater than 96.33% of all US stocks.
  • The average analyst price target of EARS is greater than 30.02% of all US stocks.

Make investment decisions regarding EARS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5851 seconds.